MENU
ABUS
AS OF
Dec 2 closing price
Price
$4.17
Change
-$0.04 (-0.95%)
Capitalization
809.68M
85 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ABUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arbutus Biopharma (ABUS) Earnings Date & Reports

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ABUS is expected to report earnings to fall 12.50% to -3 cents per share on February 26

Arbutus Biopharma ABUS Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.05
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.02
The last earnings report on November 13 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 914.73K shares outstanding, the current market capitalization sits at 809.68M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ABUS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABUS showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ABUS
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com